Calcium deposition and associated chronic diseases (atherosclerosis, diffuse idiopathic skeletal hyperostosis, and others)

被引:46
作者
Atzeni, Fabiola
Sarzi-Puttini, Piercarlo
Bevilacqua, Maonizio
机构
[1] L Sacco Univ Hosp, Rheumatol Unit, I-20157 Milan, Italy
[2] L Sacco Univ Hosp, Dept Med, Endocrine & Diabet Unit, I-20157 Milan, Italy
关键词
D O I
10.1016/j.rdc.2006.02.003
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Extracellular matrix mineralization or calcification occurs in many pathologic conditions, including atherosclerosis, medial wall calcification, diffuse idiopathic skeletal hyperostosis, and chondrocalcinosis. Vascular wall calcification is the most common and involves two mechanisms: passive calcification resulting from breakdown of the protection system and active calcification resulting from transdifferentiation of mesenchymal cells in the vascular wall to bone. Although reports are conflicting, several matrix proteins are identified as protective factors against dystrophic calcification in nonosseous tissues. Serum matrix Gla protein may be a marker of osteometabolic syndromes that cause hyperostosis and plays a role in Milwaukee shoulder syndrome.
引用
收藏
页码:413 / +
页数:15
相关论文
共 92 条
[1]
EXPRESSION OF TISSUE TRANSGLUTAMINASE IN SKELETAL TISSUES CORRELATES WITH EVENTS OF TERMINAL DIFFERENTIATION OF CHONDROCYTES [J].
AESCHLIMANN, D ;
WETTERWALD, A ;
FLEISCH, H ;
PAULSSON, M .
JOURNAL OF CELL BIOLOGY, 1993, 120 (06) :1461-1470
[2]
Matrix vesicles and calcification. [J].
H. Clarke Anderson .
Current Rheumatology Reports, 2003, 5 (3) :222-226
[3]
Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events - The St. Francis Heart Study [J].
Arad, Y ;
Goodman, KJ ;
Roth, M ;
Newstein, D ;
Guerci, AD .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (01) :158-165
[4]
Belanger T A, 2001, J Am Acad Orthop Surg, V9, P258
[5]
Bellahcene A, 1997, B CANCER, V84, P17
[6]
The skeletal attachment of tendons - tendon 'entheses' [J].
Benjamin, M ;
Kumai, T ;
Milz, S ;
Boszczyk, BM ;
Boszczyk, AA ;
Ralphs, JR .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR AND INTEGRATIVE PHYSIOLOGY, 2002, 133 (04) :931-945
[7]
Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities [J].
Bidder, M ;
Shao, JS ;
Charlton-Kachigian, N ;
Loewy, AP ;
Semenkovich, CF ;
Towler, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (46) :44485-44496
[8]
Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management [J].
Block, GA ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (06) :1226-1237
[9]
BONE MORPHOGENETIC PROTEIN EXPRESSION IN HUMAN ATHEROSCLEROTIC LESIONS [J].
BOSTROM, K ;
WATSON, KE ;
HORN, S ;
WORTHAM, C ;
HERMAN, IM ;
DEMER, LL .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1800-1809
[10]
Campbell Catherine Y, 2005, Am Heart Hosp J, V3, P105, DOI 10.1111/j.1541-9215.2005.04441.x